MedPath
NMPA Approval

Levodopa and Benserazide Hydrochloride Tablets

国药准字H20254401

May 27, 2025

Drug Information

多巴丝肼片

片剂

左旋多巴0.2g与苄丝肼50mg(相当于盐酸苄丝肼57mg)

化学药品

May 27, 2025

Company Information

Applicant Company

重庆市渝北区人和星光大道69号

Manufacturing Company

重庆市北碚区京东方大道255号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多巴丝肼片 - NMPA 批准文号 | MedPath